Agilis Steadily Advances Angelman Gene Therapy Development – Angelman Syndrome News
Angelman Syndrome News |
Agilis Steadily Advances Angelman Gene Therapy Development
Angelman Syndrome News Agilis Biotherapeutics said its Angelman syndrome gene therapy development is on track, with initial animal studies making way for tests needed before the therapy can be tried in humans. The Cambridge, Massachusetts, company announced that it plans to … |
